SCHEMBL652604

SCHEMBL652604

CCCCCCCCC(C)(O)CO

nearest known ligand 0.45

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
FDPS P14324 9/20 0.45
GGPS1 O95749 7/20 0.45
LMNA P02545 2/20 0.43
ALDH1A1 P00352 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
TSHR P16473 1/20 0.43
SMPD1 P17405 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12491787 1.00 FDPS (0.45) FDPSGGPS1LMNAALDH1A1HSD17B10
SCHEMBL16074785 1.00 FDPS (0.45) FDPSGGPS1LMNAALDH1A1HSD17B10
SCHEMBL16074821 1.00 FDPS (0.45) FDPSGGPS1LMNAALDH1A1HSD17B10
SCHEMBL16074788 1.00 FDPS (0.45) FDPSGGPS1LMNAALDH1A1HSD17B10
SCHEMBL9130650 1.00 FDPS (0.45) FDPSGGPS1LMNAALDH1A1HSD17B10
SCHEMBL16074775 1.00 FDPS (0.45) FDPSGGPS1LMNAALDH1A1HSD17B10
SCHEMBL9130408 1.00 FDPS (0.45) FDPSGGPS1LMNAALDH1A1HSD17B10
SCHEMBL16074826 1.00 FDPS (0.45) FDPSGGPS1LMNAALDH1A1HSD17B10
SCHEMBL12491913 1.00 FDPS (0.45) FDPSGGPS1LMNAALDH1A1HSD17B10
SCHEMBL12491942 1.00 FDPS (0.45) FDPSGGPS1LMNAALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113260356-B Stable donepezil-containing compositions percutaneous absorbent 东亚ST株式会社 2024-09-17 CN disclosed
CN-115516001-A Bituminous composition comprising as performance additives a mixture of isocyanates and plasticizers 巴斯夫欧洲公司 2022-12-23 CN disclosed
US-20220242808-A1 PROCESS FOR PREPARING ALKANEDIOLS SYMRISE AG (DE) 2022-08-04 US disclosed
EP-2686366-B1 BIO-BASED POLYESTER LATEX OCE TECH BV (NL) 2019-12-25 EP disclosed
US-9188866-B2 Composition for forming titanium-containing resist underlayer film and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-11-17 US disclosed
US-9176382-B2 Composition for forming titanium-containing resist underlayer film and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2015-11-03 US disclosed
US-9068091-B2 Bio-based polyester latex OCE TECHNOLOGIES B.V. (NL) 2015-06-30 US disclosed
US-20140273448-A1 COMPOSITION FOR FORMING TITANIUM-CONTAINING RESIST UNDERLAYER FILM AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-09-18 US disclosed
US-20140273447-A1 COMPOSITION FOR FORMING TITANIUM-CONTAINING RESIST UNDERLAYER FILM AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-09-18 US disclosed
EP-2686366-A1 BIO-BASED POLYESTER LATEX OCE-Technologies B.V. (NL) 2014-01-22 EP disclosed
EP-1644335-A4 TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS BRISTOL MYERS SQUIBB CO (US) 2008-06-04 EP disclosed
US-7314882-B2 Bicyclic heterocycles as cannabinoid receptor modulators BRISTOL-MYERS SQUIBB COMPANY (US) 2008-01-01 US disclosed
US-20060154955-A1 Bicyclic heterocycles as cannabinoid receptor modulators BRISTOL-MYERS SQUIBB COMPANY 2006-07-13 US disclosed
EP-1644335-A1 TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS Bristol-Myers Squibb Company (US) 2006-04-12 EP disclosed
WO-2005007628-A1 TETRAHYDROQUINOLINE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-01-27 WO disclosed
US-20050014786-A1 Tetrahydroquinoline derivatives as cannabinoid receptor modulators BRISTOL-MYERS SQUIBB COMPANY 2005-01-20 US disclosed
US-5378264-A Microemulsion formation in offgas scrubbing ALUMINUM COMPANY OF AMERICA (US) 1995-01-03 US disclosed
EP-0362430-A1 Metalworking lubricant comprising an oil-in-water microemulsion ALUMINUM COMPANY OF AMERICA (US) 1990-04-11 EP disclosed
US-4781849-A OIL, WATER SOLUBLE SURFACTANT, 1,2-ALKANEDIOL, WATER ALUMINUM COMPANY OF AMERICA (US) 1988-11-01 US disclosed
US-4781848-A HOT AND COLD ROLLING OF ALUMINUM ALUMINUM COMPANY OF AMERICA (US) 1988-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220242808-A1 PROCESS FOR PREPARING ALKANEDIOLS ADH1A, ADH1C, HSD17B12 FDPS 350/4885GGPS1 142/4885LMNA 1796/4885
US-20050014786-A1 Tetrahydroquinoline derivatives as cannabinoid receptor modulators CNR2, CNR1, OPRL1 FDPS 1416/4885GGPS1 585/4885LMNA 4479/4885
US-20060154955-A1 Bicyclic heterocycles as cannabinoid receptor modulators CNR1, CNR2, GPR18 FDPS 1882/4885GGPS1 1044/4885LMNA 2633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.